highly significantP-value < 0.001
Furthermore, while GLP-1 RAs reduced bone resorption (β-CTX SMD −1.43 [−2.01, −0.86]), SGLT2 inhibitors increased it (SMD + 0.52 [−0.01, 1.05]), resulting in a highly significant difference (P-value < 0.001).
Furthermore, while GLP-1 RAs reduced bone resorption (β-CTX SMD −1.43 [−2.01, −0.86]), SGLT2 inhibitors increased it (SMD + 0.52 [−0.01, 1.05]), resulting in a highly significant difference (P-value < 0.001).
The effect on P1NP, another formation marker, was positive but did not reach statistical significance (SMD 0.14 [−0.03, 0.31]).